Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Wall Street
Price Targets
ARWR Price Targets Summary
Arrowhead Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for ARWR is 48.38 USD with a low forecast of 23.23 USD and a high forecast of 84 USD.
ARWR Last Price Targets
Arrowhead Pharmaceuticals Inc
The latest public price target was made on Sep 3, 2024 by David Lebowitz from Citigroup , who expects ARWR stock to rise by 38% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.
Analyst | Price Target | Date | Article |
---|---|---|---|
David Lebowitz
Citigroup
|
27
USD
Upside 38% |
4 months ago
Sep 3, 2024
|
Citi Reiterates Neutral Rating on Arrowhead Pharma (ARWR)
StreetInsider
|
Patrick Trucchio
H.C. Wainwright
|
60
USD
Upside 207% |
6 months ago
Jul 5, 2024
|
Arrowhead Pharma (ARWR) PT Lowered to $60 at H.C. Wainwright
StreetInsider
|
Andrea Tan
Goldman Sachs
|
31
USD
Upside 58% |
7 months ago
Jun 5, 2024
|
Goldman Sachs Starts Arrowhead Pharma (ARWR) at Neutral
StreetInsider
|
Luca Issi
RBC Capital
|
50
USD
Upside 156% |
7 months ago
May 30, 2024
|
RBC Capital Reiterates Outperform Rating on Arrowhead Pharma (ARWR)
StreetInsider
|
Unknown Analyst
RBC Capital
|
77
USD
Upside 294% |
1 year ago
Feb 7, 2023
|
RBC Capital Maintains Outperform on Arrowhead Pharma, Lowers Price Target to $77
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ARWR's stock price target?
Price Target
48.38
USD
According to Wall Street analysts, the average 1-year price target for ARWR is 48.38 USD with a low forecast of 23.23 USD and a high forecast of 84 USD.
What is Arrowhead Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
372%
For the last 8 years the compound annual growth rate for Arrowhead Pharmaceuticals Inc's revenue is 43%. The projected CAGR for the next 3 years is 372%.